info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Breathing Disorders & Treatment Market Analysis

ID: MRFR//1046-HCR | 90 Pages | Author: Rahul Gotadki| June 2024

As respiratory disorders are complicated, the Breathing Disorders Treatment market is shaped by their landscape. This emphasizes the need for new respiratory care methods. To properly manage breathing disorders, one must grasp the various factors that affect this dynamic healthcare sector.
Asthma, COPD, and respiratory infections are on the rise, influencing market dynamics. Due to the increased number of patients, effective and accessible respiratory treatments are needed.
Inhalation medication developments affect the market owing to their influence. Innovations in delivery devices including inhalers, nebulizers, and others provide targeted and effective medicines that enhance respiratory illness management.
Market growth is helping biologics and targeted medicine advances. Drugs tailored to respiratory ailments' molecular targets have changed the treatment of breathing difficulties. For severe asthma, monoclonal antibodies are employed.
Technical advances affect respiratory device market dynamics. Smart inhalers, connected devices, and wearable technology help monitor and control respiratory disorders, but they also affect patient outcomes and market growth.
Patient education and awareness campaigns affect the sector. Knowledge about prevention measures, early symptom assessment, and sickness management programs empowers people to control their respiratory health. This may affect market patterns.
The market is heavily influenced by respiratory therapy and healthcare regulations. New drug approvals, safety regulations, and respiratory health policies shape the competitive environment.
Telemedicine and remote patient monitoring are changing the industry. Medical professionals may remotely monitor and treat breathing disorders using these technologies, making respiratory therapy more accessible, especially during follow-up consultations.
Air quality and other environmental factors affect market dynamics. Due to the link between environmental toxins and respiratory disorders, preventive strategies and technology to reduce external causes of breathing issues have been prioritized.
Treatment procedures that include respiratory rehabilitation and physiotherapy affect market dynamics. Comprehensive breathing illness treatment involves pharmaceuticals and rehabilitation programs to improve lung function and respiratory health.
Because respiratory disorders impact everyone, global cooperation is needed. International collaboration in respiratory research, exchanging best practices, and addressing global health problems all help create a more coherent approach to breathing illnesses, influencing market dynamics.
Respiratory therapy availability and cost-effectiveness are crucial. The cost of drugs, equipment, and healthcare services affects patient access and adherence to treatment regimens, which affects market dynamics and healthcare outcomes.

Breathing disorders treatment Market Scenario


The Breathing Disorders Treatment market is expected to reach USD 141097.21 Million by 2030 at 16.90% CAGR during the forecast period 2022-2030. Breathing disorders are the one that affects the lungs and other parts of respiratory system. These breathing disorders include chronic sinusitis, asthma, and chest congestion. The person suffering from breathing problems faces various symptoms such as runny nose, nasal congestion, itchy or watery eyes, cough, chest congestion, labored breathing, wheezing, and shallow breathing. The primary factors driving the growth of breathing disorder & treatment market are increasing allergic reaction that causes breathing problem, pollen grain reaction, low blood pressure, or hypertension in individuals.


According to the World Health Organization, it was estimated, that 383,000 people died due to asthma in 2015. The rising prevalence of asthma among the population is likely to boost the market growth.


However, stringent government regulation related to drug launch, side effects, and allergic reactions due to steroids may hinder the market growth during the forecasted period


Segmentation


The breathing disorders treatment market has been segmented into drug class, indication, and end users.


By drug class the market has been segmented into antibiotics, non-steroidal anti-inflammatory drug (NSAIDS), cough suppressant, nasal decongestant, and others.


 On the basis of indication, the market has been segmented into allergic rhinitis, chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis (CF), pulmonary hypertension, idiopathic pulmonary fibrosis and others.


On the basis of end user, the market has been segmented into hospital, clinics, retail pharmacies, and online pharmacies.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The breathing disorders treatment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European breathing disorders treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The breathing disorders treatment market in Asia-Pacific has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific. The breathing disorders treatment industry in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players



  • AstraZeneca

  • GlaxoSmithKline

  • Merck Sharp & Dohme Corp.

  • Abbott

  • Medtronic plc

  • Hoffmann-La Roche Ltd

  • Novartis AG

  • Reddy’s Laboratories

  • Amgen

  • Aurobindo Pharma.

  • Bayer AG

  • Biogen

  • Others


Regional Market Summary


 Breathing disorders treatment Market Share (%), by Region, 2018  Breathing disorders treatment Market


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports


Geographically, the market has been segmented, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. It is estimated that Americas dominated the breathing disorders treatment market owing to the increasing prevalence of respiratory disorders, rising geriatric population and heart-related problems. According to the Centers for Disease Control and Prevention 2017, 8.9 million adults were diagnosed with chronic bronchitis in the US and 135,268 number of deaths occurred due to chronic lower respiratory diseases. Such high prevalence of respiratory diseases in the US is expected to boost the market growth in America.


Europe stood second largest in the breathing disorders treatment market owing to the increasing health problems such as hypertension, stress, obesity, and changing lifestyle among the population. The increase pollution and environmental changes are also contributing in the demand for breathing treatment.  According, to the article published on NHS Digital 617,000 patients were under treatment in NHS hospitals because of obesity in 2016. The increasing obesity leads to cause breathing problems and hyperventilation to the patient, which will increase the demand for breathing treatment.


Asia-Pacific was anticipated to be the rapidly growing region for the breathing disorders treatment market. The market is expected to witness growth owing to the increasing population and rising demand for pharmaceutical products required for the treatment of asthma, chronic obstructive pulmonary disease (COPD), wheezing, and other breathing-related disorders. The prevalence of asthma is high in developing countries and cities, such as Japan, Hong Kong, and Singapore which support the market growth.


The market in the Middle East and Africa holds a low share in the breathing disorders treatment market due to the presence of a low number of healthcare facilities, low per capita income and people living in underdeveloped countries are not much aware of the upcoming treatment methods. However, the market is expected to witness growth due to increasing hospitals and rising demand for the products in the Middle East.


Breathing disorders treatment Market, by Drug Type



  • Antibiotics

  • Non-Steroidal Anti-Inflammatory Drug (NSAIDS)

  • Cough Suppressant

  • Nasal Decongestant

  • Others


Breathing disorders treatment Market, by Indication



  • Chronic Obstructive Pulmonary Disease (COPD)

  • Asthma

  • Allergic Rhinitis

  • Pulmonary Hypertension

  • Cystic Fibrosis (CF)

  • Idiopathic Pulmonary Fibrosis

  • Others


Breathing disorders treatment Market, by End User



  • Hospital and Clinics

  • Retail Pharmacies

  • Online Pharmacies


Breathing disorders treatment Market, by Region



  • Americas


    • North America


      • US

      • Canada


    • Latin America




  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe




  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • Latin Korea

    • Rest of Asia-Pacific




  • Middle East & Africa


    • Middle East

    • Africa



Intended Audience



  • Bipolar Disorders and Treatment centers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.